======= PSMD5 ======= == Gene Information == * **Official Symbol**: PSMD5 * **Official Name**: proteasome 26S subunit, non-ATPase 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5711|5711]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q16401|Q16401]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PSMD5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PSMD5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604452|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a chaperone during the assembly of the 26S proteasome, specifically of the base subcomplex of the PA700/19S regulatory complex (RC). In the initial step of the base subcomplex assembly is part of an intermediate PSMD5:PSMC2:PSMC1:PSMD2 module which probably assembles with a PSMD10:PSMC4:PSMC5:PAAF1 module followed by dissociation of PSMD5. {ECO:0000269|PubMed:19412159, ECO:0000269|PubMed:19490896}. |Proteasom PSMB| |proteasome regulatory particle assembly| |proteasome regulatory particle, base subcomplex| |proteasome assembly| |proteasome accessory complex| |proteasome complex| |regulation of cellular amino acid metabolic process| |regulation of hematopoietic stem cell differentiation| |antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent| |regulation of transcription from RNA polymerase II promoter in response to hypoxia| |antigen processing and presentation of exogenous peptide antigen via MHC class I| |NIK/NF-kappaB signaling| |regulation of cellular amine metabolic process| |anaphase-promoting complex-dependent catabolic process| |regulation of hematopoietic progenitor cell differentiation| |negative regulation of G2/M transition of mitotic cell cycle| |SCF-dependent proteasomal ubiquitin-dependent protein catabolic process| |interleukin-1-mediated signaling pathway| |Wnt signaling pathway, planar cell polarity pathway| |antigen processing and presentation of peptide antigen via MHC class I| |negative regulation of cell cycle G2/M phase transition| |regulation of establishment of planar polarity| |stimulatory C-type lectin receptor signaling pathway| |innate immune response activating cell surface receptor signaling pathway| |regulation of stem cell differentiation| |tumor necrosis factor-mediated signaling pathway| |regulation of transcription from RNA polymerase II promoter in response to stress| |regulation of DNA-templated transcription in response to stress| |non-canonical Wnt signaling pathway| |positive regulation of canonical Wnt signaling pathway| |regulation of cellular ketone metabolic process| |Fc-epsilon receptor signaling pathway| |cellular response to interleukin-1| |negative regulation of canonical Wnt signaling pathway| |T cell receptor signaling pathway| |antigen processing and presentation of exogenous peptide antigen| |positive regulation of Wnt signaling pathway| |regulation of mRNA stability| |regulation of morphogenesis of an epithelium| |antigen processing and presentation of exogenous antigen| |regulation of RNA stability| |cellular response to hypoxia| |antigen processing and presentation of peptide antigen| |regulation of G2/M transition of mitotic cell cycle| |cellular response to decreased oxygen levels| |response to interleukin-1| |regulation of mRNA catabolic process| |negative regulation of Wnt signaling pathway| |regulation of cell cycle G2/M phase transition| |negative regulation of mitotic cell cycle phase transition| |cellular response to oxygen levels| |antigen processing and presentation| |negative regulation of cell cycle phase transition| |innate immune response-activating signal transduction| |cellular response to tumor necrosis factor| |Fc receptor signaling pathway| |regulation of animal organ morphogenesis| |activation of innate immune response| |response to tumor necrosis factor| |protein deubiquitination| |regulation of canonical Wnt signaling pathway| |antigen receptor-mediated signaling pathway| |protein modification by small protein removal| |protein polyubiquitination| |negative regulation of mitotic cell cycle| |proteasome-mediated ubiquitin-dependent protein catabolic process| |negative regulation of cell cycle process| |regulation of mRNA metabolic process| |positive regulation of innate immune response| |response to hypoxia| |proteasomal protein catabolic process| |Wnt signaling pathway| |response to decreased oxygen levels| |cell-cell signaling by wnt| |regulation of Wnt signaling pathway| |post-translational protein modification| |positive regulation of response to biotic stimulus| |MAPK cascade| |response to oxygen levels| |signal transduction by protein phosphorylation| |regulation of mitotic cell cycle phase transition| |cell surface receptor signaling pathway involved in cell-cell signaling| |regulation of small molecule metabolic process| |regulation of cell cycle phase transition| |immune response-activating cell surface receptor signaling pathway| |regulation of hemopoiesis| |regulation of innate immune response| |positive regulation of defense response| |immune response-regulating cell surface receptor signaling pathway| |positive regulation of multi-organism process| |regulation of response to biotic stimulus| |posttranscriptional regulation of gene expression| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |immune response-activating signal transduction| |negative regulation of cell cycle| |proteolysis involved in cellular protein catabolic process| |immune response-regulating signaling pathway| |positive regulation of response to external stimulus| |cellular protein catabolic process| |activation of immune response| |regulation of mitotic cell cycle| |cytokine-mediated signaling pathway| |protein catabolic process| |protein ubiquitination| |regulation of cell cycle process| |regulation of defense response| |protein modification by small protein conjugation| |regulation of multi-organism process| |regulation of cellular catabolic process| |cellular protein-containing complex assembly| |positive regulation of immune response| |cellular macromolecule catabolic process| |protein phosphorylation| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |cellular response to cytokine stimulus| |macromolecule catabolic process| |organonitrogen compound catabolic process| |regulation of anatomical structure morphogenesis| |regulation of response to external stimulus| |response to cytokine| |cell-cell signaling| |regulation of immune response| |positive regulation of immune system process| |response to abiotic stimulus| |regulation of cell cycle| |negative regulation of signal transduction| |proteolysis| |transmembrane transport| |phosphorylation| |negative regulation of cell communication| |negative regulation of signaling| |regulation of response to stress| |protein-containing complex assembly| |negative regulation of response to stimulus| |positive regulation of signal transduction| |regulation of immune system process| |intracellular signal transduction| |cellular response to stress| |organic substance catabolic process| |cellular catabolic process| |regulation of cell differentiation| |positive regulation of cell communication| |positive regulation of signaling| |protein-containing complex subunit organization| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 6865 * **Expression level (log2 read counts)**: 4.76 {{:chemogenomics:nalm6 dist.png?nolink |}}